Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3105 results found
Expand All
Apply All
3105 results found

Out of the bat cave, into the virus fire
Share
Good Day BIO Newsletter  •  May 1, 2020
Happy Friday. In case you missed it, Gilead Chairman and CEO Daniel O’Day joined NBC’s Savanah Guthrie on TODAY to discuss the latest development with the company’s experimental treatment remdesivir. As Guthrie notes during the interview, “We are in the midst of a pandemic and humanity is literally depending on companies like yours.” Watch the segment here.We’re taking you into the weekend with a look at why it’s more important than ever to continue research into zoonotic diseases—and what it will take to get us back to work and normal life after the pandemic. Here are 780 words, or 4 minutes, to start your weekend.
Read More

Out of the bat cave, into the virus fire
Share
Good Day BIO Newsletter  •  May 1, 2020
Happy Friday. In case you missed it, Gilead Chairman and CEO Daniel O’Day joined NBC’s Savanah Guthrie on TODAY to discuss the latest development with the company’s experimental treatment remdesivir. As Guthrie notes during the interview, “We are in the midst of a pandemic and humanity is literally depending on companies like yours.” Watch the segment here.We’re taking you into the weekend with a look at why it’s more important than ever to continue research into zoonotic diseases—and what it will take to get us back to work and normal life after the pandemic. Here are 780 words, or 4 minutes, to start your weekend.
Read More

This technology might block and destroy the coronavirus genome
Share
Good Day BIO Newsletter  •  April 30, 2020
Just two more days until the weekend. Today, we have a new episode of the I AM BIO Podcast, featuring a company using breakthrough RNA technology that might be able to block and destroy the genome of the coronavirus. We’re also looking at how biotech could save your summer stone fruits. Here are just under 800 words, just under 4 minutes.
Read More

Thank essential workers – and PPE – for tonight’s pork chops
Share
Good Day BIO Newsletter  •  April 29, 2020
JUST IN: For those just getting out of bed, STAT News is reporting that COVID-19 patients are responding to Gilead’s remdesivir – a sign of hope on the horizon. We also have news from the Trump administration on the meat industry and essential workers—and why PPE is so important. And, we’re closing out World Immunization Awareness Week with some big news on a COVID-19 vaccine. Here are about 965 words, just under 5 minutes.
Read More

New SEC rules will help small biotechs deliver the medicines we need
Share
Good Day BIO Newsletter  •  April 28, 2020
ICYMI: New SEC rules that went into effect yesterday will help small biotechs research the medicines we need for COVID-19 and many other diseases. There's also more news on one BIO member doing incredible research with animal biotech to help humans fight this pandemic. Here are around 800 words, 4 minutes.
Read More

BIO BOARDLIST
Share

A vital dose of vaccine education
Share
Good Day BIO Newsletter  •  April 27, 2020
It’s World Immunization Awareness Week, with the theme Vaccines Work for All. The world is watching the biotech industry race to find a COVID-19 vaccine—yet anti-vaccination rhetoric is, unfortunately, alive and well. Today’s new episode of the I AM BIO Podcast explores the importance of vaccines, and how a COVID-19 vaccine will bring the world out of this crisis. Here are around 730 words, 3 minutes, 30 seconds.
Read More

COVID-19’s true origins
Share
Good Day BIO Newsletter  •  April 24, 2020
For your weekend listening, we have a new episode of the I AM BIO Podcast with a world-renowned zoonotic disease expert who explores the origins of the coronavirus—and some of it may surprise you. Here are 605 words, or 3 minutes.
Read More

Attorney for Agriculture & Environment
Share
Position Title:  Attorney for Agriculture & Environment Department:  Legal  Reports to:   1) President, Advocacy, Law and Public Policy Division, and                       2) General Counsel & SVP Legal Primary Purpose of the Position:  Provide regulatory counseling and litigation management regarding legal, policy, and regulatory matters for the Agriculture and Environment groups at BIO. This advocacy counseling primarily involves any litigation and regulatory activities related to USDA, EPA and FDA, as well as any related legislative and advocacy activities.  Also serve as in-house counsel providing legal services for the organization, including supervising compliance and contractual matters, as well as training for BIO attorneys and staff. Responsibilities: Provide legal assistance, training and supervision, as needed, on contracts and compliance, as well as state, federal, and international legislative, regulatory, and trade-related matters for BIO on non-health matters, including evaluating and developing comments on regulatory proposals, proposed legislation, and other documents. Serve as legal counsel to the Agriculture and Environment groups at BIO, including regulatory counsel and support, litigation management and support, antitrust counsel, corporate legal support, and advice and support on governance and compliance issues. Serve as counsel to section Boards for Agriculture and Environment, and all related staff-level committees, work streams and working groups. Provide legal assistance on voluntary industry self-regulatory initiatives (e.g., product stewardship and transparency) and communication campaigns related to Agriculture and Environment.  Manage the efficient use of outside counsel within all of the above subject matters. Assist with other legal activities of the organization, as requested by the General Counsel (GC) and…
Read More

J&J launches live COVID-19 web series
Share
Good Day BIO Newsletter  •  April 23, 2020
Mark your stay-at-home calendar! Next Tuesday, April 28, join Medexprim and Graticule for a free webinar on how global collaboration can help us build much-needed real-world data for treating COVID-19. Click here to register...because if there's one thing we love more than Netflix right now, it's collaboration. Today, we have an update on the global food supply chain and why One Health matters, plus links to Johnson & Johnson’s new web series about a COVID-19 vaccine, in around 715 words, or 3 minutes, 30 seconds.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 227
  • 228
  • 229
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO